Anne L. Angiolillo, M.D., MS, is the director of the Leukemia and Lymphoma Program at Children's National Hospital. She specializes in acute lymphoblastic leukemia, non-Hodgkin lymphoma and asparaginase pharmacokinetics.
Dr. Angiolillo has been named a "Top Doctor" by Washingtonian Magazine and has been included in the Best Doctors in America annual database since 2005.
In addition, she recently chaired the Children’s Oncology Group, OG Study, AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy). The results of AALL0932 have become available and have demonstrated outstanding outcomes.